Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 3Unknown 2Terminated 2Withdrawn 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2

Conditions

Neoplasms 85Carcinoma, Non-Small-Cell Lung 75Breast Neoplasms 73Recurrence 64Colorectal Neoplasms 62Pancreatic Neoplasms 59Multiple Myeloma 57Melanoma 56Carcinoma, Hepatocellular 56Advanced Solid Tumor 55Leukemia, Myeloid, Acute 53Advanced Solid Tumors 53Lymphoma 52Neoplasm Metastasis 50Stomach Neoplasms 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Solid Tumor 39Lymphoma, B-Cell 39Ovarian Neoplasms 38Lymphoma, Non-Hodgkin 37Lung Neoplasms 35Glioblastoma 35Prostatic Neoplasms 34Leukemia 28Head and Neck Neoplasms 27Leukemia, Lymphocytic, Chronic, B-Cell 26Uterine Cervical Neoplasms 25Burkitt Lymphoma 24Esophageal Neoplasms 22Urinary Bladder Neoplasms 18

Interventions

Rifampin 1Itraconazole 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Advanced Malignant Neoplasm × Clear all
NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
40 enrolled
Other neoplasm

Advanced Malignant Neoplasm

NCT05867563 2023-07-10

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
71 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡